Lin BioScience, Inc. (TPEX:6696)
389.00
-10.50 (-2.63%)
Mar 9, 2026, 2:00 PM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 32.26 billion as of March 9, 2026. Its market cap has increased by 183.95% in one year.
Market Cap
32.26B
Enterprise Value
29.58B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
389.00
Market Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 32.26B, an increase of 1,006.37%. That is a compound annual growth rate of 38.25%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 36.42B |
| Lumosa Therapeutics | 27.12B |
| Oneness Biotech | 26.27B |
| Polaris Group | 23.58B |
| Sunmax Biotechnology | 21.21B |
| EirGenix | 18.10B |
| TaiMed Biologics | 14.62B |
| AP Biosciences | 14.46B |